Delcath Systems Inc (DCTH)

[Gator328]

No way that shareholders would approve a .05/share deal. We'd be better off forcing the company into bankruptcy, and letting the US Trustee appoint an examiner to liquidate the assets. I guarantee if that were to happen there would be a bidding war for the technology, as "outdated" as you may think it is -- it works, and it's safe, and it's effective (see: Europe).

Much more money has been spent on far more speculative biotech products. The Chemsat system could in theory be applied to other types of cancer. There is a potential multi-billion dollar market. The cost to develop the technology is in the hundreds of millions.

I think in a liquidation scenario, we're looking at a multi-party bidding war where the final yield is at least .50/share, probably closer to .75/share.

The shell of the company alone, being that it is current with all SEC regulations, and has some net operating losses as well (which are hard to preserve in any sort of merger but it's entirely possible with a good lawyer who is familiar with §382 of the IRS code), would be worth around .05/share to a private company looking to go public in a reverse merger.

The Chemsat technology is worth at least $80M-$100M, as the market seems to be showing now, and probably a lot more if the next set of data comes back positive.

Enjoy your 4th of July! Be safe!